Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Debt (2021 - 2025)

LifeStance Health (LFST) has disclosed Total Debt for 5 consecutive years, with $265.9 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 4.95% to $265.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $265.9 million through Dec 2025, down 4.95% year-over-year, with the annual reading at $265.9 million for FY2025, 4.95% down from the prior year.
  • Total Debt for Q4 2025 was $265.9 million at LifeStance Health, down from $269.4 million in the prior quarter.
  • The five-year high for Total Debt was $288.5 million in Q4 2023, with the low at $167.9 million in Q2 2021.
  • Average Total Debt over 5 years is $243.9 million, with a median of $259.3 million recorded in 2023.
  • The sharpest move saw Total Debt skyrocketed 40.47% in 2022, then fell 4.95% in 2025.
  • Over 5 years, Total Debt stood at $171.5 million in 2021, then soared by 40.47% to $241.0 million in 2022, then grew by 19.71% to $288.5 million in 2023, then decreased by 3.0% to $279.8 million in 2024, then fell by 4.95% to $265.9 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $265.9 million, $269.4 million, and $272.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.